IQVIA Oncology Biomarker Monitor (OBM) is a syndicated study designed to collect key insights on the oncology biomarker testing process from the perspective of diagnostic and molecular pathology laboratories.

This study collects information on the biomarker testing process itself, providing key insights that contribute to deeper understanding and enhancing the biomarker testing practice.